Literature DB >> 760741

Impairment of hepatic drug metabolism in alcoholics.

A W Harman, D B Frewin, B G Priestly, C B Alexander.   

Abstract

1 The effects of chronic ethanol intake on the elimination kinetics of antipyrine were determined in nineteen male alcoholic subjects with comparison made to fourteen male volunteers. 2 Half-lives were longer and clearance values less in the alcoholic group. 3 Significant rank correlations were found between half-life and clearance when compared with various biochemical parameters of liver function measured in the plasma of the alcoholics. 4 These results show that a significant proportion of the alcoholics studied had impaired hepatic drug metabolizing capacity and that the activity of hepatic microsomal enzymes may be related to the extent of ethanol induced liver damage in these subjects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760741      PMCID: PMC1429615          DOI: 10.1111/j.1365-2125.1979.tb00895.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Increased urinary excretion of D-glucaric acid in alcoholism.

Authors:  E Mezey
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-12

2.  The fate of antipyrine in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

3.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 4.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

5.  Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats.

Authors:  P S Misra; A Lefévre; H Ishii; E Rubin; C S Lieber
Journal:  Am J Med       Date:  1971-09       Impact factor: 4.965

6.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

7.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

8.  Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.

Authors:  A Kappas; K E Anderson; A H Conney; A P Alvares
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

9.  Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.

Authors:  A W Harman; R K Penhall; B G Priestly; D B Frewin; P J Phillips; A R Clarkson
Journal:  Aust N Z J Med       Date:  1977-08

10.  Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol.

Authors:  E Rubin; C S Lieber
Journal:  Science       Date:  1968-11-08       Impact factor: 47.728

View more
  2 in total

1.  Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

Authors:  M S Roberts; R H Rumble; S Wanwimolruk; D Thomas; P M Brooks
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Antipyrine clearance in patients with Gilbert's syndrome.

Authors:  T Ishizaki; K Chiba; T Sasaki
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.